Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT05879120
Status:
WITHDRAWN
Last Update Posted:
2024-11-20
First Post:
2023-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-18
First Submit QC Date:
None
Study First Post Date:
2023-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL